- Current report filing (8-K)
18 8월 2012 - 5:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT
OF 1934
Date of report (Date of earliest event reported): August 13, 2012
HANSEN MEDICAL, INC.
(Exact name of registrant as specified in charter)
|
|
|
|
|
Delaware
|
|
001-33151
|
|
14-1850535
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
800 East Middlefield Road
Mountain View, California 94043
(Address of principal executive offices
and zip code)
Registrants telephone number, including area code: (650) 404-5800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory.
(b) On August 13, 2012, Michael T. MacKinnon, our Vice President of North American Sales Operations, resigned
from his employment with us, effective as of August 31, 2012, in order to become president of a privately-held, venture capital backed medical device company. Our Vice President of Marketing and Business Development, Joseph Guido, will assume
responsibility for leading our North American Sales Operations on an interim basis.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
|
|
H
ANSEN
M
EDICAL
, I
NC
.
(Registrant)
|
|
|
Date: August 17, 2012
|
|
/s/ P
ETER
J. M
ARIANI
|
|
|
Peter J. Mariani
Chief
Financial Officer
|
3
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024